Evolution of Bone Disease at 2 Years After Transplantation: A Single-Center Study

Transplantation Proceedings

Volumn 41, Issue 8, 2009, Pages 3063-3066

  Falkiewicz, K ^a   Boratynska M ^a   Zmonarski, S C ^a   Milewicz, A ^a   Patrzalek D ^a   Biecek, P ^a   Klinger, M ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCITRIOL; COLLAGEN TYPE 1; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OSTEOCALCIN; PARATHYROID HORMONE; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; BONE DENSITY; BONE DISEASE; BONE MASS; BONE REMODELING; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM;

ADULT; BONE DENSITY; BONE DISEASES; CALCITRIOL; CREATININE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OSTEOCALCIN; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; POSTOPERATIVE COMPLICATIONS; PROCOLLAGEN;

EID: 70350493759     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.09.041     Document Type: Article

References (10)

1. Grotz W., Mundinger A., Gugel B., et al. Bone mineral density after kidney tranasplantation: A cross sectional study in 190 graft recipients up to 20 years after transplantation. Transplantation 59 (1995) 982
2. Carlini R.G., Rojas E., Weisinger J.R., et al. Bone disease in patients with long-term renal transplantation and normal renal function. Am J Kidney Dis 36 (2000) 160
3. Heaf J., Tvedegaard E., Kanstrup I.L., et al. Bone loss after transplantation: role of hyperparathyroidism, acidosis, cyclosporine and systemic disease. Clin Transplant 14 (2000) 457
4. Cvetkovic M., Mann G.N., Romero D.F., et al. The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK 506 on bone mineral metabolism in vivo. Transplantation 57 (1994) 1231
5. ter Meulen C.G., van Riemsdijk I., Hene R.J., et al. No important influence of limited steroid exposure on bone mass during the first year after renal transplantation: A prospective, randomized, multicenter study. Transplantation 78 (2004) 101
6. Goffin E., Devogelaer J.-P., Lalaoui A., et al. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation. Transplant Int 15 (2002) 73
7. Goffin E., Devogelaer J.-P., Depresseux G., et al. Evaluation of bone mineral density after renal transplantation under a tacrolimus based immunosupression: a pilot study. Clin Nephrol 59 (2003) 190
8. van de Ham E.C., Kooman J.P., Christiaans M.H., et al. The influence of early steroid withdrawal on body composition and bone mineral density in renal transplantation patients. Transplant Int 16 (2003) 82
9. Inoue T., Kawamura I., Matsuo M., et al. Lesser reduction In bone mineral density by the immunosuppressant, FK506, compared with cyclosporine in rats. Transplantation 70 (2000) 774
10. Fleseriu M., and Licata A.A. Failure of successful renal transplant to produce appropriate leves of 1,25-dihydroxyvitamin D. Osteoporos Int 18 (2007) 363